Core Measure Community Acquired Pneumonia
Today hospitals as businesses, as well as health care institutions, face many obstacles while caring, treating, and rehabilitating patients during their hospital stay. The community as a whole tends to follow a pattern of trends that include specific health conditions including Acute Myocardial Infarction (AMI), Congestive Heart Failure (CHF), and Community Acquired Pneumonia (CAP). These three conditions are part of a collection of diagnoses that have been deemed the title of Core Measures. Core Measures and National Patient Safety Goals were created with the intention of delivering evidence based practice to the bedside to ensure continuity of care. …show more content…
The Center for Medicare and Medicaid Services (CMS) established the Core Measures in 2000 and began reporting the data publicly in 2003. The Joint Commission on Accreditation on Healthcare Organizations (JCAHO) created National Patient Safety Goals to promote specific patient safety and to also support the implementation of Core Measures. Other Stakeholders involved with the Core Measure development and implementation include clinicians, hospitals, consumers, and medical societies. (H&HN 2009)
The goal of the core measurements in terms of best practice and standardization of care include a very specific treatment regiment for each established condition. For example, when a patient is admitted to the hospital with Community Acquired Pneumonia (CAP), the standard of care within the CAP core measure includes initiating antibiotic treatment within four hours. This standard of practice has been associated with a 15% lower risk of mortality. As with this example, each core measure has been established as a result of successful and specific evidence based …show more content…
There was also a chest x-ray done that showed whiteout of the right lung and possible infiltration or tumors in the right lung as well as an enlarged heart. JH had a CT scan done of her brain which came back unremarkable. On September 10th, a chest tube was inserted on JH draining approximately 400ml of serosanguineous fluid. A sample of this was sent to the lab for a gram stain and culture and cytology, it came back negative for bacterial growth and no cancerous cells were seen. A follow-up x-ray on the 12th showed not changes, indicating that she had a mass in her chest and not just fluid. Following the core measures protocol, blood cultures were drawn in the ER and JH was started on Levaquin; the patient was also vaccinated with pneumococcal and tDap. After her blood cultures came back negative, Levaquin was discontinued on September 12th. JH has continued to take her home meds she brought in while hospitalized. Her medication list